Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$390M |
| 2 |
Alibaba
BABA
|
+$330M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$253M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$325M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$303M |
| 3 |
PX
Praxair Inc
PX
|
+$213M |
| 4 |
COL
Rockwell Collins
COL
|
+$103M |
| 5 |
ANDV
Andeavor
ANDV
|
+$96.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.36% |
| 2 | Financials | 15.21% |
| 3 | Healthcare | 13.81% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSTC
2551
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $74K | ﹤0.01% |
1,211
+404
| +50% | +$24.1K |
|
2552
Arrow Financial
AROW
$670M
| $73K | ﹤0.01% |
2,636
+466
| +21% | +$13.8K |
|
|
KE
2553
Kimball Electronics
KE
$644M
| $73K | ﹤0.01% |
4,746
+652
| +16% | +$11.5K |
|
2554
Kura Oncology
KURA
$817M
| $73K | ﹤0.01% |
5,175
+923
| +22% | +$12.2K |
|
2555
nLIGHT
LASR
$4.24B
| $73K | ﹤0.01% |
4,119
+3,096
| +303% | +$58.6K |
|
2556
Sasol
SSL
$7.01B
| $73K | ﹤0.01% |
2,484
| – | – |
|
|
ABTX
2557
DELISTED
Allegiance Bancshares
ABTX
| $73K | ﹤0.01% |
2,249
+571
| +34% | +$21.3K |
|
|
CRCM
2558
DELISTED
CARE.COM, INC.
CRCM
| $73K | ﹤0.01% |
3,784
-9,672
| -72% | -$176K |
|
|
OLBK
2559
DELISTED
Old Line Bancshares, Inc.
OLBK
| $73K | ﹤0.01% |
2,758
+416
| +18% | +$12.1K |
|
2560
Citizens
CIA
$235M
| $72K | ﹤0.01% |
9,626
+2,378
| +33% | +$18.7K |
|
2561
Winmark
WINA
$1.3B
| $72K | ﹤0.01% |
456
+83
| +22% | +$12.7K |
|
|
TVRD
2562
Tvardi Therapeutics
TVRD
$18.8M
| $72K | ﹤0.01% |
154
| – | – |
|
2563
Financial Institutions
FISI
$836M
| $71K | ﹤0.01% |
2,788
+474
| +20% | +$13.4K |
|
|
GLDD
2564
DELISTED
Great Lakes Dredge & Dock
GLDD
| $71K | ﹤0.01% |
10,782
+1,658
| +18% | +$10.8K |
|
2565
Hackett Group
HCKT
$290M
| $71K | ﹤0.01% |
4,383
+600
| +16% | +$11.2K |
|
2566
QCR Holdings
QCRH
$1.72B
| $71K | ﹤0.01% |
2,211
| – | – |
|
2567
Rhythm Pharmaceuticals
RYTM
$7.59B
| $71K | ﹤0.01% |
2,675
| – | – |
|
2568
Q32 Bio
QTTB
$490M
| $71K | ﹤0.01% |
175
+89
| +103% | +$33.7K |
|
2569
Anterix
ATEX
$1.94B
| $70K | ﹤0.01% |
1,885
+588
| +45% | +$23K |
|
2570
Calix
CALX
$2.42B
| $70K | ﹤0.01% |
7,145
+677
| +10% | +$5.89K |
|
2571
The Bancorp
TBBK
$2.99B
| $70K | ﹤0.01% |
8,785
| – | – |
|
|
AXDX
2572
DELISTED
Accelerate Diagnostics
AXDX
| $69K | ﹤0.01% |
600
+187
| +45% | +$27.7K |
|
2573
Option Care Health
OPCH
$3.55B
| $69K | ﹤0.01% |
4,840
| – | – |
|
2574
RadNet
RDNT
$5.27B
| $69K | ﹤0.01% |
6,801
| – | – |
|
2575
Rigel Pharmaceuticals
RIGL
$749M
| $69K | ﹤0.01% |
3,019
+250
| +9% | +$7.05K |
|
Similar funds
Legal & General Group's Q4 2018 Portfolio in Review
As of Q4 2018, Legal & General Group held 3,449 positions worth $129B, down 7.6% from $140B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Legal & General Group deployed $9.23B of net new capital in Q4 2018, opening 63 new positions and adding to 2,242 existing holdings. Its largest new stake was Linde: 2,465,565 shares worth $381M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $53.7M trimmed.
- Legal & General Group's largest Q4 2018 buy was Linde: 2,465,565 shares worth $381M.
- Legal & General Group added most to Alibaba in Q4 2018, an estimated $330M increase.
- Legal & General Group's biggest Q4 2018 reduction was Dell, cutting an estimated $53.7M.
- Legal & General Group fully exited Aetna Inc in Q4 2018, selling an estimated $325M.
- Legal & General Group's ten largest holdings make up 16% of its $129B portfolio in Q4 2018.
- Legal & General Group opened 63 new positions and closed 67 in Q4 2018.
- Legal & General Group's portfolio value fell 7.6% quarter-over-quarter to $129B.
Based on Legal & General Group's 13F filing for Q4 2018, filed 15 Feb 2019.